<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38424312</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-&#x3b1;.</ArticleTitle><Pagination><StartPage>4974</StartPage><MedlinePgn>4974</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4974</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-55696-0</ELocationID><Abstract><AbstractText>The cGAS-STING pathway appears to contribute to dysregulated inflammation during coronavirus disease 2019 (COVID-19); however, inflammatory factors related to long COVID are still being investigated. In the present study, we evaluated the association of cGAS and STING gene expression levels and plasma IFN-&#x3b1;, TNF-&#x3b1; and IL-6 levels with COVID-19 severity in acute infection and long COVID, based on analysis of blood samples from 148 individuals, 87 with acute COVID-19 and 61 in the post-COVID-19 period. Quantification of gene expression was performed by real-time PCR, and cytokine levels were quantified by ELISA and flow cytometry. In acute COVID-19, cGAS, STING, IFN-&#x3b1;, TNF-&#x3b1;, and IL-6 levels were higher in patients with severe disease than in those with nonsevere manifestations (p&#x2009;&lt;&#x2009;0.05). Long COVID was associated with elevated cGAS, STING and IFN-&#x3b1; levels (p&#x2009;&lt;&#x2009;0.05). Activation of the cGAS-STING pathway may contribute to an intense systemic inflammatory state in severe COVID-19 and, after infection resolution, induce an autoinflammatory disease in some tissues, resulting in long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Maria Alice Freitas</ForeName><Initials>MAF</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil. alicefarma@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil. alicefarma@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Wandrey Roberto Dos Santos</ForeName><Initials>WRDS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Keise Adrielle Santos</ForeName><Initials>KAS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Leonn Mendes Soares</ForeName><Initials>LMS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoras</LastName><ForeName>Ednelza da Silva Gra&#xe7;a</ForeName><Initials>EDSG</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Sandra Souza</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Erika Ferreira Dos</ForeName><Initials>EFD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Fl&#xe1;via P&#xf3;voa da</ForeName><Initials>FPD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarges</LastName><ForeName>Kevin Matheus Lima de</ForeName><Initials>KML</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantanhede</LastName><ForeName>Marcos Henrique Damasceno</ForeName><Initials>MHD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Mioni Thieli Figueiredo Magalh&#xe3;es de</ForeName><Initials>MTFM</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Andr&#xe9;a Luciana Soares da</ForeName><Initials>ALSD</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Mauro de Meira</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Maria de Nazar&#xe9; do Socorro de Almeida</ForeName><Initials>MNDSA</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Fab&#xed;ola Brasil Barbosa</ForeName><Initials>FBB</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Rosilene da</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana</LastName><ForeName>Giselle Maria Rachid</ForeName><Initials>GMR</Initials><AffiliationInfo><Affiliation>Laboratory of Basic Research On Malaria, Parasitology Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>T&#xe2;nia do Socorro Souza</ForeName><Initials>TDSS</Initials><AffiliationInfo><Affiliation>Laboratory of Basic Research On Malaria, Parasitology Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Institute of Medical Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Par&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ver&#xed;ssimo</LastName><ForeName>Adriana de Oliveira Lameira</ForeName><Initials>AOL</Initials><AffiliationInfo><Affiliation>Bel&#xe9;m Adventist Hospital, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Mayara da Silva</ForeName><Initials>MDS</Initials><AffiliationInfo><Affiliation>Bel&#xe9;m Adventist Hospital, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Daniele Freitas</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Arbovirology and Hemorrhagic Fevers Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Carla Pinheiro da</ForeName><Initials>CPD</Initials><AffiliationInfo><Affiliation>Arbovirology and Hemorrhagic Fevers Section, Evandro Chagas Institute, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Juliana Abreu Lima</ForeName><Initials>JAL</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Iran Barros</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cayres-Vallinoto</LastName><ForeName>Izaura Maria Vieira</ForeName><Initials>IMV</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasil-Costa</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Immunology, Section of Virology, Instituto Evandro Chagas, Health and Environment Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio Sim&#xf5;es</ForeName><Initials>JAS</Initials><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Biological and Health Sciences, University of the State of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio Magno</ForeName><Initials>LFM</Initials><AffiliationInfo><Affiliation>Center of Biological and Health Sciences, University of the State of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Eduardo Jos&#xe9; Melo Dos</ForeName><Initials>EJMD</Initials><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Genetics of Complex Diseases, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallinoto</LastName><ForeName>Antonio Carlos Ros&#xe1;rio</ForeName><Initials>ACR</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biology of Infectious and Parasitic Agents, Institute of Biological Sciences, Federal University of Par&#xe1;, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Virology, Evandro Chagas Institute, Department of Science, Technology, Innovation and Strategic Health Inputs, Ministry of Health of Brazil, Ananindeua, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>n&#xb0; 304835/2022-6</GrantID><Agency>Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico</Agency><Country/></Grant><Grant><GrantID>n&#xb0; 401235/2020-3; n&#xb0; 302935/2021-5; INCT-VER n&#xba; 406360/2022-7</GrantID><Agency>Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico</Agency><Country/></Grant><Grant><GrantID>09/2021</GrantID><Agency>Secretariat of Science, Technology and Higher, Professional and Technological Education</Agency><Country/></Grant><Grant><GrantID>n&#xb0; 005/2020</GrantID><Agency>Funda&#xe7;&#xe3;o Amaz&#xf4;nia de Amparo a Estudos e Pesquisa do Par&#xe1;</Agency><Country/></Grant><Grant><GrantID>PAPQ/2023</GrantID><Agency>Federal University of Para</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554156">IFNA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578390">cGAS protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="N">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38424312</ArticleId><ArticleId IdType="pmc">PMC10904751</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-55696-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-55696-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Global Clinical Platform for the Clinical Characterization of COVID-19: Statistical Analysis Plan. https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-Analytic-plan-2021.1 (2021).</Citation></Reference><Reference><Citation>Wang F, et al. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: Evidence from a retrospective observational study. Int. J. Epidemiol. 2021;49(6):1940&#x2013;1950. doi: 10.1093/ije/dyaa180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa180</ArticleId><ArticleId IdType="pmc">PMC7665537</ArticleId><ArticleId IdType="pubmed">33150437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagant C, et al. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int. J. Infect. Dis. 2020;101:342&#x2013;345. doi: 10.1016/j.ijid.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7544772</ArticleId><ArticleId IdType="pubmed">33039609</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Torres MK, et al. The complexity of SARS-CoV-2 infection and the COVID-19 pandemic. Front. Microbiol. 2022;13:789882. doi: 10.3389/fmicb.2022.789882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.789882</ArticleId><ArticleId IdType="pmc">PMC8870622</ArticleId><ArticleId IdType="pubmed">35222327</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins, F.S. NIH Launches New Initiative to Study &#x201c;Long COVID&#x201d;. National Institutes of Health; Bethesda, MD, USA. Available at: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.</Citation></Reference><Reference><Citation>Parums DV. Editorial: Long COVID, or post-COVID syndrome, and the global impact on health care. Med. Sci. Monit. 2021;27:e933446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194290</ArticleId><ArticleId IdType="pubmed">34092779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Landhuis EW. How primary care physicians can recognize and treat long COVID. JAMA. 2023;329(20):1727&#x2013;1729. doi: 10.1001/jama.2023.6604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.6604</ArticleId><ArticleId IdType="pubmed">37133827</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, et al. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. An update on innate immune responses during SARS-CoV-2 infection. Viruses. 2021;13(10):2060. doi: 10.3390/v13102060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13102060</ArticleId><ArticleId IdType="pmc">PMC8541410</ArticleId><ArticleId IdType="pubmed">34696490</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J. Med. Virol. 2022;94(11):5174&#x2013;5188. doi: 10.1002/jmv.27965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27965</ArticleId><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461(7265):788&#x2013;792. doi: 10.1038/nature08476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08476</ArticleId><ArticleId IdType="pmc">PMC4664154</ArticleId><ArticleId IdType="pubmed">19776740</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber GN. STING-dependent cytosolic DNA sensing pathways. Trends Immunol. 2014;35(2):88&#x2013;93. doi: 10.1016/j.it.2013.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.10.010</ArticleId><ArticleId IdType="pubmed">24309426</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Barber GN. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-&#x3ba;B activation through TBK1. J. Virol. 2014;88(10):5328&#x2013;5341. doi: 10.1128/JVI.00037-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00037-14</ArticleId><ArticleId IdType="pmc">PMC4019140</ArticleId><ArticleId IdType="pubmed">24600004</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz KM, Neidermyer WJ, Tan YJ, Whelan SPJ, Kagan JC. STING-dependent translation inhibition restricts RNA virus replication. Proc Natl Acad Sci USA. 2018;115(9):E2058&#x2013;E2067. doi: 10.1073/pnas.1716937115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1716937115</ArticleId><ArticleId IdType="pmc">PMC5834695</ArticleId><ArticleId IdType="pubmed">29440426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS One. 2012;7(2):e30802. doi: 10.1371/journal.pone.0030802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030802</ArticleId><ArticleId IdType="pmc">PMC3270028</ArticleId><ArticleId IdType="pubmed">22312431</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre S, et al. Fernandez-Sesma A. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 2012;8(10):e1002934. doi: 10.1371/journal.ppat.1002934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002934</ArticleId><ArticleId IdType="pmc">PMC3464218</ArticleId><ArticleId IdType="pubmed">23055924</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm CK, et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nat. Commun. 2016;7:10680. doi: 10.1038/ncomms10680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10680</ArticleId><ArticleId IdType="pmc">PMC4762884</ArticleId><ArticleId IdType="pubmed">26893169</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabell AC, et al. Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir. Elife. 2018;7:e31919. doi: 10.7554/eLife.31919.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.31919</ArticleId><ArticleId IdType="pmc">PMC5860865</ArticleId><ArticleId IdType="pubmed">29557779</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeldt CJ, et al. SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-&#x3ba;B. Commun. Biol. 2022;5(1):45. doi: 10.1038/s42003-021-02983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02983-5</ArticleId><ArticleId IdType="pmc">PMC8755718</ArticleId><ArticleId IdType="pubmed">35022513</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio JD, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603(7899):145&#x2013;151. doi: 10.1038/s41586-022-04421-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The immune response and immunopathology of COVID-19. Front. Immunol. 2020;11:2037. doi: 10.3389/fimmu.2020.02037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02037</ArticleId><ArticleId IdType="pmc">PMC7479965</ArticleId><ArticleId IdType="pubmed">32983152</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, et al. Polymorphisms in the MBL2 gene are associated with the plasma levels of MBL and the cytokines IL-6 and TNF-&#x3b1; in severe COVID-19. Front. Immunol. 2023;14:1151058. doi: 10.3389/fimmu.2023.1151058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1151058</ArticleId><ArticleId IdType="pmc">PMC10149935</ArticleId><ArticleId IdType="pubmed">37138871</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima LLP, et al. STING and cGAS gene expressions were downregulated among HIV-1-infected persons after antiretroviral therapy. Virol. J. 2021;18(1):78. doi: 10.1186/s12985-021-01548-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01548-6</ArticleId><ArticleId IdType="pmc">PMC8047565</ArticleId><ArticleId IdType="pubmed">33858455</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-&#x2206;&#x2206;CT method. Methods. 2001;25(4):402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/ (2022).</Citation></Reference><Reference><Citation>Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455(7213):674&#x2013;678. doi: 10.1038/nature07317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07317</ArticleId><ArticleId IdType="pmc">PMC2804933</ArticleId><ArticleId IdType="pubmed">18724357</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat. Rev. Immunol. 2015;15(2):87&#x2013;103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: A complex web of host defenses. Annu. Rev. Immunol. 2014;32:513&#x2013;545. doi: 10.1146/annurev-immunol-032713-120231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032713-120231</ArticleId><ArticleId IdType="pmc">PMC4313732</ArticleId><ArticleId IdType="pubmed">24555472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014;14(1):36&#x2013;49. doi: 10.1038/nri3581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3581</ArticleId><ArticleId IdType="pmc">PMC4084561</ArticleId><ArticleId IdType="pubmed">24362405</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS crosstalk in inflammation. Trends Cell Biol. 2016;26(4):249&#x2013;261. doi: 10.1016/j.tcb.2015.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.12.002</ArticleId><ArticleId IdType="pubmed">26791157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Narazaki M, Masuda K, Kishimoto T. Regulation of IL-6 in immunity and diseases. Adv. Exp. Med. Biol. 2016;941:79&#x2013;88. doi: 10.1007/978-94-024-0921-5_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-024-0921-5_4</ArticleId><ArticleId IdType="pubmed">27734409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, et al. IL-6 drives T cell death to participate in lymphopenia in COVID-19. Int Immunopharmacol. 2022;111:109132. doi: 10.1016/j.intimp.2022.109132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109132</ArticleId><ArticleId IdType="pmc">PMC9359506</ArticleId><ArticleId IdType="pubmed">35964413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer B, et al. Early IFN-&#x3b1; signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54(11):2650&#x2013;2669.e14. doi: 10.1016/j.immuni.2021.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8416549</ArticleId><ArticleId IdType="pubmed">34592166</ArticleId></ArticleIdList></Reference><Reference><Citation>Smail SW, Babaei E, Amin K, Abdulahad WH. Serum IL-23, IL-10, and TNF-&#x3b1; predict in-hospital mortality in COVID-19 patients. Front. Immunol. 2023;14:1145840. doi: 10.3389/fimmu.2023.1145840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1145840</ArticleId><ArticleId IdType="pmc">PMC10239952</ArticleId><ArticleId IdType="pubmed">37283736</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos NP, et al. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ances-try-informative marker (AIM) panel. Hum. Mutat. 2010;31:84&#x2013;90. doi: 10.1002/humu.21159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21159</ArticleId><ArticleId IdType="pubmed">19953531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni MG, et al. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021;46:100745. doi: 10.1016/j.blre.2020.100745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10(2):386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021;3(6):774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322(1):C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao T, Liu J, Leng J, Cai L. The cGAS-STING pathway: More than fighting against viruses and cancer. Cell Biosci. 2021;11(1):209. doi: 10.1186/s13578-021-00724-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00724-z</ArticleId><ArticleId IdType="pmc">PMC8670263</ArticleId><ArticleId IdType="pubmed">34906241</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155(3):688&#x2013;698. doi: 10.1016/j.cell.2013.09.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.09.049</ArticleId><ArticleId IdType="pmc">PMC3881181</ArticleId><ArticleId IdType="pubmed">24119841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremiah N, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 2014;124(12):5516&#x2013;5520. doi: 10.1172/JCI79100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI79100</ArticleId><ArticleId IdType="pmc">PMC4348945</ArticleId><ArticleId IdType="pubmed">25401470</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK. Type I interferon in the pathogenesis of lupus. J. Immunol. 2014;192(12):5459&#x2013;5468. doi: 10.4049/jimmunol.1002795.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002795</ArticleId><ArticleId IdType="pmc">PMC4083591</ArticleId><ArticleId IdType="pubmed">24907379</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. 2022;376(6599):1261&#x2013;1265. doi: 10.1126/science.add4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20(1):172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc. Health. 2021;5(9):677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 2021;224(11):1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61(1):2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Gutman D, Saijo S, Barber GN. STING manifests self DNA-dependent inflammatory disease. Proc. Natl. Acad. Sci. USA. 2012;109(47):19386&#x2013;19391. doi: 10.1073/pnas.1215006109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1215006109</ArticleId><ArticleId IdType="pmc">PMC3511090</ArticleId><ArticleId IdType="pubmed">23132945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall A, et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012;36(1):120&#x2013;131. doi: 10.1016/j.immuni.2011.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.11.018</ArticleId><ArticleId IdType="pmc">PMC3269499</ArticleId><ArticleId IdType="pubmed">22284419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, et al. Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Cancer Cell. 2018;33(5):862&#x2013;873.e5. doi: 10.1016/j.ccell.2018.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2018.03.027</ArticleId><ArticleId IdType="pmc">PMC6177226</ArticleId><ArticleId IdType="pubmed">29706455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao KM, Marshak-Rothstein A, Fitzgerald KA. Type-1 interferon-dependent and -independent mechanisms in cyclic GMP-AMP synthase-stimulator of interferon genes-driven auto-inflammation. Curr. Opin. Immunol. 2023;80:102280. doi: 10.1016/j.coi.2022.102280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102280</ArticleId><ArticleId IdType="pubmed">36638547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D. Role of kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells. 2021;10(7):1603. doi: 10.3390/cells10071603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071603</ArticleId><ArticleId IdType="pmc">PMC8306609</ArticleId><ArticleId IdType="pubmed">34206739</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique LA, et al. The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. Ann. Clin. Transl. Neurol. 2023;10(8):1338&#x2013;1352. doi: 10.1002/acn3.51825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51825</ArticleId><ArticleId IdType="pmc">PMC10424655</ArticleId><ArticleId IdType="pubmed">37318955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>